| Ytd | 45.89% | |
| 1y | 51.88% |
| Open | 9.53 | Prev Close | 9.65 | Low | 8.71 | High | 9.56 | Mkt Cap | 551.31M |
| Vol | 1.45M | Avg Vol | 1.15M | EPS | -1.29 | P/E | N/A | Forward P/E | N/A |
| Beta | 1.45 | Short Ratio | 2.36 | Inst. Own | 62.77% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 12.49 | 200-d Avg | 8.31 | 1yr Est | 53.70 |
SLN News
Silence Therapeutics (SLN) might move higher on growing optimism about its earnings prospects, which
U.S. stock futures fell as Novartis plunged 12.7% after pelacarsen’s Phase III trial missed its endp
Gainers iSpecimen (NASDAQ:ISPC) shares increased by 10.4% to $1.7 during Friday's after-market
Morgan Stanley analyst Michael Ulz maintains Silence Therapeutics (NASDAQ:SLN) with a Overweight
Gainers Jin Medical International (NASDAQ:ZJYL) shares rose 58.1% to $3.4 during Monday's regul
Silence Therapeutics reports positive Phase 2 SANRECO trial data for divesiran in polycythemia vera.
BWMN gained 55.1%, HZO rose 45.8%, ABCL gained 35.6%, SLN rose 34.3%, ACHR gained 19.5%, NESR gained
Gainers Jin Medical International (NASDAQ:ZJYL) stock rose 70.7% to $3.67 during Monday's pre-m
Silence Therapeutics (NASDAQ:SLN) reported quarterly losses of $(0.09) per share which beat the anal
Avalon Holdings (NYSE:AWX) shares rose 10.5% in pre-market trading after posting strong Q2 earnings
Silence Therapeutics ($SLN) stock surges as Cantor predicts key August Phase 2 data will be a major
Cantor Fitzgerald analyst Prakhar Agrawal initiates coverage on Silence Therapeutics (NASDAQ:SLN)
U.S. stock futures mostly higher, Nasdaq futures gain 100+ points. Sophia Genetics (SOPH) falls afte
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Silence Therapeutics (NASDAQ:SLN)
Silence Therapeutics says SANRECO data show sustained polycythemia vera benefits as analysts weigh d
New analyses from the Phase 1 SANRECO study demonstrate potential improvements in PV symptoms and qu
Silence Therapeutics (NASDAQ:SLN) reported quarterly losses of $(0.11) per share which beat the anal
Urgent.ly shares surged in pre-market trading after agreement to be acquired by Agero for $5.50 per
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarte
Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for it
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterl
Tuesday's session saw 286 companies set new 52-week lows.
On Monday, 147 stocks made new 52-week lows.
During Friday's session, 149 stocks hit new 52-week lows.
On Wednesday, 81 companies hit new 52-week lows.
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly
Gainers Kalera Public Limited Company (NASDAQ: KAL) jumped 76.9% to close at $0.1610 on Wednesday
On Thursday, 126 companies set new 52-week lows.
On Friday, 1043 companies hit new 52-week lows.
Wednesday's session saw 784 companies set new 52-week lows.
During Tuesday's trading, 505 companies set new 52-week lows.
During Monday's morning trading, 285 companies set new 52-week highs.
Friday morning saw 331 companies set new 52-week highs.
This morning 194 companies reached new 52-week highs.
Monday morning saw 558 companies set new 52-week highs.
During the morning session on Monday, 372 stocks hit new 52-week highs.